BioMed Research International / 2015 / Article / Tab 1

Clinical Study

Disorders of MicroRNAs in Peripheral Blood Mononuclear Cells: As Novel Biomarkers of Ankylosing Spondylitis and Provocative Therapeutic Targets

Table 1

Clinical features of the AS participants.

CharacteristicsAS ()

Disease duration, mean ± SD years7.9 ± 0.8
BASDAI, mean ± SD 5.25 ± 1.62
BASFI, mean ± SD 46.5 ± 23.6
CRP, mean ± SD mg/L30.5 ± 23.5
ESR, mean ± SD mm39.9 ± 29.5
Medications before etanercept therapy, taking/not taking
 Steroids, last 3 months6/34
 DMARDs, last 3 months27/13
 NSAIDs, last 1 month29/11

AS, ankylosing spondylitis; HC, healthy control; SD, standard deviation; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; BASFI, Bath Ankylosing Spondylitis Functional Index; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; DMARDs, disease-modifying antirheumatic drugs; NSAIDs, nonsteroidal anti-inflammatory drugs.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.